Raynaud's phenomenon: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 15: | Line 15: | ||
{{Raynaud's phenomenon}} | {{Raynaud's phenomenon}} | ||
'''Editors-In-Chief:''' Asghar Fakhri, M.D. | '''Editors-In-Chief:''' Asghar Fakhri, M.D.; Duane S. Pinto, M.D. and [[User:C Michael Gibson|C. Michael Gibson, M.S., M.D.]] | ||
{{SK}} Raynaud phenomenon; Raynaud's disease | |||
==[[Raynaud's phenomenon overview|Overview]]== | ==[[Raynaud's phenomenon overview|Overview]]== | ||
==[[Raynaud's phenomenon pathophysiology|Pathophysiology]]== | ==[[Raynaud's phenomenon pathophysiology|Pathophysiology]]== | ||
| Line 39: | Line 39: | ||
==Treatment== | ==Treatment== | ||
[[Raynaud's phenomenon medical therapy|Medical therapy]] | [[Raynaud's phenomenon primary prevention|Primary prevention]] | [[Raynaud's phenomenon secondary prevention|Secondary prevention]] | [[Raynaud's phenomenon cost-effectiveness of therapy|Financial costs]] | [[Raynaud's phenomenon future or investigational therapies|Future therapies]] | [[Raynaud's phenomenon medical therapy|Medical therapy]] | [[Raynaud's phenomenon primary prevention|Primary prevention]] | [[Raynaud's phenomenon secondary prevention|Secondary prevention]] | [[Raynaud's phenomenon cost-effectiveness of therapy|Financial costs]] | [[Raynaud's phenomenon future or investigational therapies|Future therapies]] | ||
==Case Studies== | |||
:[[Raynaud's phenomenon case study one|Case #1]] | |||
== Related | == Related Chapters == | ||
* [[CREST syndrome]] | * [[CREST syndrome]] | ||
| Line 46: | Line 48: | ||
* [http://www.niams.nih.gov/hi/topics/raynaud/ar125fs.htm Overview] at [[National Institutes of Health]] | * [http://www.niams.nih.gov/hi/topics/raynaud/ar125fs.htm Overview] at [[National Institutes of Health]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
Revision as of 17:14, 8 November 2012
For patient information click here
| Raynaud's phenomenon | |
 | |
|---|---|
| Hands with Raynaud's phenomenon | |
| ICD-10 | I73.0 |
| ICD-9 | 443.0 |
| DiseasesDB | 25933 |
| MeSH | D011928 |
|
Raynaud's phenomenon Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Raynaud's phenomenon On the Web |
|
American Roentgen Ray Society Images of Raynaud's phenomenon |
Editors-In-Chief: Asghar Fakhri, M.D.; Duane S. Pinto, M.D. and C. Michael Gibson, M.S., M.D.
Synonyms and keywords: Raynaud phenomenon; Raynaud's disease
Overview
Pathophysiology
Causes
Differentiating Raynaud's phenomenon from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other imaging findings | Other diagnostic studies
Treatment
Medical therapy | Primary prevention | Secondary prevention | Financial costs | Future therapies
Case Studies
Related Chapters
External links